The bounty of nature for changing the cancer landscape

Molecular Nutrition & Food Research
Aamir AhmadFazlul H Sarkar

Abstract

The landscape of cancer has changed considerably in past several years, due mainly to aggressive screening, accumulation of data from basic and epidemiological studies, and the advances in translational research. Natural anticancer agents have always been a part and parcel of cancer research. The initial focus on natural anticancer agents was in context of their cancer chemopreventive properties but their ability to selectively target oncogenic signaling pathways has also been recognized. In light of the rapid advancements in our understanding of the role of microRNAs, cancer stem cells, and epigenetic events in cancer initiation and progression, a number of natural anticancer agents are showing promise in vitro, in vivo as well as in preclinical studies. Moreover, parent structures of natural agents are being extensively modified with the hope of improving efficacy, specificity, and bioavailability. In this article, we focus on two natural agents, 3,3'-diindolylmethane and garcinol, along with 3,4-difluorobenzo curcumin, a synthetic analog of natural agent curcumin. We showcase how these anticancer agents are changing cancer landscape by modulating novel microRNAs, epigenetic factors, and cancer stem cell markers. These activi...Continue Reading

References

Nov 17, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deeba N SyedHasan Mukhtar
Feb 7, 2008·Journal of Cellular Biochemistry·Chengyin MinGail E Sonenshein
May 27, 2008·Cancer Letters·Naghma Khan, Hasan Mukhtar
Mar 10, 2009·The Journal of Nutritional Biochemistry·Wing Pui Tsang, Tim Tak Kwok
Jul 7, 2009·Drug Discovery Today·Frank J Dekker, Hidde J Haisma
Sep 4, 2009·Journal of Hematology & Oncology·Subhash PadhyeFazlul H Sarkar
Dec 4, 2009·Translational Oncology·Yingjie YuAdhip Pn Majumdar
Jan 29, 2010·Journal of Cellular Biochemistry·Aamir AhmadFazlul H Sarkar
Feb 4, 2010·Cancer Research·Yiwei LiFazlul H Sarkar
Mar 12, 2010·Pharmaceutical Research·Imtiaz A Siddiqui, Hasan Mukhtar
Aug 18, 2010·Cancer Metastasis Reviews·Naghma Khan, Hasan Mukhtar
Oct 7, 2010·Nutrition and Cancer·Imtiaz A SiddiquiHasan Mukhtar
Dec 17, 2010·Current Drug Targets·Joseph HuangClarissa Gerhauser
Dec 17, 2010·Pharmaceutical Research·Shailender Singh KanwarAdhip P N Majumdar
Dec 24, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Imtiaz A SiddiquiHasan Mukhtar
Jan 11, 2011·Archives of Biochemistry and Biophysics·Mary NdiayeNihal Ahmad
Feb 22, 2012·International Journal of Nanomedicine·Imtiaz A SiddiquiHasan Mukhtar
Mar 29, 2012·Journal of Hematology & Oncology·Catherine Labbaye, Ugo Testa
May 26, 2012·Cancer Cell·Daniel D De CarvalhoPeter A Jones
Jun 26, 2012·Biochemical and Biophysical Research Communications·Alexandre SemovValery Alakhov
Jul 19, 2012·Epigenetics : Official Journal of the DNA Methylation Society·Yiwei LiFazlul H Sarkar

❮ Previous
Next ❯

Citations

Aug 27, 2016·BMC Complementary and Alternative Medicine·Florian PohligRüdiger von Eisenhart-Rothe
Jul 23, 2016·International Journal of Molecular Sciences·Soo Mi Kim
Mar 3, 2018·International Journal of Molecular Sciences·Ammad Ahmad FarooqiAamir Ahmad
Feb 20, 2019·International Journal of Molecular Sciences·Mohd FarhanAamir Ahmad
Mar 10, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Haseeb ZubairAjay Pratap Singh
Nov 22, 2019·Anti-cancer Agents in Medicinal Chemistry·Rumana AhmadArvind K Srivastava
Sep 18, 2020·Antioxidants·Shamee Bhattacharjee, Roderick H Dashwood
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Javed IqbalAkhtar Munir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.